Rankings
▼
Calendar
RCKT Q2 2016 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$538M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$9M
EPS (Diluted)
$-1.30
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$687,000
Balance Sheet
Total Assets
$100M
Total Liabilities
$4M
Stockholders' Equity
$95M
Cash & Equivalents
$39M
← FY 2016
All Quarters
Q3 2016 →
